Developing research at the convergence of the life, clinical, engineering and physical sciences is the key focus of the CRUK Convergence Science Centre. The Centre supports emerging ideas with its own seed funding scheme: the Development Fund. The aim is to promote new approaches and accelerate the adoption of new innovations in clinical practice and research. The primary intention of this seed funding is to develop the preliminary data required to build a more substantive project that could attract funding from external sources.
Developing new technologies, methodologies, and tools to address urgent unmet clinical needs in cancer healthcare and to solve intractable cancer problems is the key focus of the CRUK Convergence Science Centre.
Applications will be accepted in any area of cancer-related tools, technologies and methodologies spanning prevention, detection, diagnosis, and treatment as outlined in the Centre’s priority list (see guidelines). The focus of the CRUK Convergence Science Centre is to merge EPS and cancer research expertise to develop new technologies, methodologies and tools that directly put cancer patient wellbeing at the centre of their design. Priority will be given to the development of innovative cancer technologies, methodologies, and tools.
The Centre offers training opportunities for clinical and non-clinical students; our approach harnesses the diverse expertise and infrastructure of a globally renowned university and a world leading influential cancer research institute. In addition, we create custom-built skills courses that complements the research undertaken by our students to equip them with the skills and confidence to succeed in any sector including academia, industry, business, politics, and healthcare. Our model builds unique student cohorts that focusses on topical issues in cancer research and utilises novel engineering and physical sciences approach to address them – this is what we mean by convergence science.